| Oct 18, 2009
Brooke Shields beams into the camera, her sea-green eyes framed by long, dark lashes, doing the cha-cha and helping a friend blow out birthday candles. In the ubiquitous commercials for the lash-growing product Latisse, the actress and model is saying...
| Dec 16, 2009
Taking a prescription drug for a positive cosmetic side effect -- at the risk of experiencing other unwanted side effects -- may seem risky. But it's a risk many American women have shown themselves happy to take.
Latisse, originally a glaucoma drug...
| Oct 20, 2009
Attention aging baby boomers, 60ish single gentlemen, high-powered CEOs and laid-off professionals preparing for job interviews: The wait is over. Dysport, the new botulinum toxin product touted as a quicker, cheaper and longer-lasting way to banish...
| Nov 9, 2009
It's hard to tell which recently revealed tidbits about tennis legend Andre Agassi's life, published on Oct. 30 as excerpts of his upcoming autobiography, has caused more of a buzz: His yearlong flirtation with crystal meth or the fact that the glorious...
| Nov 16, 2009
For about $100 a month, you could have the long, thick, dark eyelashes that you've always wanted.
But Latisse, a drug that can treat the new medical condition "inadequate eyelashes," also has a few unpleasant side effects. It may grow excessive hair in...
| Nov 20, 2009
| 8:45 AM
WASHINGTON -- They call it the "Botax." The White House and Senate Democrats have turned to a proposal to tax breast implants, tummy tucks, wrinkle-smoothing injections and other procedures as they search for ways to pay for costly health care overhaul...
| Dec 7, 2009
Taking a prescription drug for a cosmetic side effect -- at the risk of other side effects -- may seem risky. But it's a risk that many Americans, mostly women, have shown themselves happy to take.
Latisse, originally a glaucoma drug marketed under the...